| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A call for us all to resist the resistance
|
Fitzsimmons, Leah
|
|
2015
|
15 |
7 |
p. 774-
1 p.
|
artikel
|
| 2 |
A forgotten epidemic that changed medicine: measles in the US Army, 1917–18
|
Morens, David M
|
|
2015
|
15 |
7 |
p. 852-861
10 p.
|
artikel
|
| 3 |
Antimicrobial resistance: what's needed
|
Tillotson, Glenn
|
|
2015
|
15 |
7 |
p. 758-760
3 p.
|
artikel
|
| 4 |
Anti-vaxxing: a privilege of the fortunate
|
Kamadjeu, Raoul
|
|
2015
|
15 |
7 |
p. 766-767
2 p.
|
artikel
|
| 5 |
Are all Staphylococcus aureus equal?
|
Lawes, Timothy
|
|
2015
|
15 |
7 |
p. 762-
1 p.
|
artikel
|
| 6 |
Assessing the epidemiological effect of wolbachia for dengue control
|
Lambrechts, Louis
|
|
2015
|
15 |
7 |
p. 862-866
5 p.
|
artikel
|
| 7 |
Correction
|
|
|
2015
|
15 |
7 |
p. 761-
1 p.
|
artikel
|
| 8 |
Corrections
|
|
|
2015
|
15 |
7 |
p. 761-
1 p.
|
artikel
|
| 9 |
Corrections
|
|
|
2015
|
15 |
7 |
p. 761-
1 p.
|
artikel
|
| 10 |
Corrections
|
|
|
2015
|
15 |
7 |
p. 761-
1 p.
|
artikel
|
| 11 |
Cover illustration
|
Aluwihare, Arjuna P R
|
|
2015
|
15 |
7 |
p. 767-
1 p.
|
artikel
|
| 12 |
Cover illustration – Editor's reply
|
McConnell, John
|
|
2015
|
15 |
7 |
p. 767-
1 p.
|
artikel
|
| 13 |
Crossing the minefield of disease names
|
The Lancet Infectious Diseases,
|
|
2015
|
15 |
7 |
p. 747-
1 p.
|
artikel
|
| 14 |
Dengue transmission during the 2014 FIFA World Cup in Brazil
|
Aguiar, Maíra
|
|
2015
|
15 |
7 |
p. 765-766
2 p.
|
artikel
|
| 15 |
Design, recruitment, and microbiological considerations in human challenge studies
|
Darton, Thomas C
|
|
2015
|
15 |
7 |
p. 840-851
12 p.
|
artikel
|
| 16 |
Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
|
Perez-Molina, José A
|
|
2015
|
15 |
7 |
p. 775-784
10 p.
|
artikel
|
| 17 |
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|
Arribas, José R
|
|
2015
|
15 |
7 |
p. 785-792
8 p.
|
artikel
|
| 18 |
Ebola: the hidden toll
|
Hamel, Mary J
|
|
2015
|
15 |
7 |
p. 756-757
2 p.
|
artikel
|
| 19 |
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study
|
|
|
2015
|
15 |
7 |
p. 793-802
10 p.
|
artikel
|
| 20 |
Future challenges for clinical care of an ageing population infected with HIV: a modelling study
|
Smit, Mikaela
|
|
2015
|
15 |
7 |
p. 810-818
9 p.
|
artikel
|
| 21 |
Geometry: a secret weapon in the fight against viruses
|
Ranscombe, Peter
|
|
2015
|
15 |
7 |
p. 773-
1 p.
|
artikel
|
| 22 |
Health-care-associated infections
|
Havers, Sally M
|
|
2015
|
15 |
7 |
p. 763-764
2 p.
|
artikel
|
| 23 |
Health-care-associated infections – Authors' reply
|
Zingg, Walter
|
|
2015
|
15 |
7 |
p. 764-
1 p.
|
artikel
|
| 24 |
Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis
|
Rao, V Bhargavi
|
|
2015
|
15 |
7 |
p. 819-824
6 p.
|
artikel
|
| 25 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
2015
|
15 |
7 |
p. 771-
1 p.
|
artikel
|
| 26 |
Limited use for dual treatment with boosted protease inhibitors plus lamivudine in first-line antiretroviral therapy
|
Orrell, Catherine
|
|
2015
|
15 |
7 |
p. 748-749
2 p.
|
artikel
|
| 27 |
Lower-dose efavirenz: what is needed before implementation?
|
Maartens, Gary
|
|
2015
|
15 |
7 |
p. 749-751
3 p.
|
artikel
|
| 28 |
Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis
|
Walker, Patrick G T
|
|
2015
|
15 |
7 |
p. 825-832
8 p.
|
artikel
|
| 29 |
Online future of The Lancet Infectious Diseases review papers
|
McConnell, John
|
|
2015
|
15 |
7 |
p. 760-
1 p.
|
artikel
|
| 30 |
Predictions of geriatric HIV in 2030
|
Vance, David E
|
|
2015
|
15 |
7 |
p. 753-754
2 p.
|
artikel
|
| 31 |
Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis
|
Payne, Helen
|
|
2015
|
15 |
7 |
p. 803-809
7 p.
|
artikel
|
| 32 |
Relief and worries about hepatitis C in sub-Saharan Africa
|
Njouom, Richard
|
|
2015
|
15 |
7 |
p. 754-755
2 p.
|
artikel
|
| 33 |
Research brief
|
Bradbury, Jane
|
|
2015
|
15 |
7 |
p. 772-
1 p.
|
artikel
|
| 34 |
Risk of infection after the Nepal earthquake
|
Bagcchi, Sanjeet
|
|
2015
|
15 |
7 |
p. 770-771
2 p.
|
artikel
|
| 35 |
Role of co-trimoxazole for urinary tract infections in developing countries
|
Leblebicioglu, Hakan
|
|
2015
|
15 |
7 |
p. 764-765
2 p.
|
artikel
|
| 36 |
Rubella is eliminated from the Americas
|
Kirby, Tony
|
|
2015
|
15 |
7 |
p. 768-769
2 p.
|
artikel
|
| 37 |
Schistosomiasis reaches Europe
|
Boissier, Jérôme
|
|
2015
|
15 |
7 |
p. 757-758
2 p.
|
artikel
|
| 38 |
Stepped-wedge trial design to evaluate Ebola treatments
|
Piszczek, Jolanta
|
|
2015
|
15 |
7 |
p. 762-763
2 p.
|
artikel
|
| 39 |
The downside of success: confirmation of HIV infection in early treated children
|
Sutcliffe, Catherine G
|
|
2015
|
15 |
7 |
p. 751-752
2 p.
|
artikel
|
| 40 |
The HIV care continuum in Latin America: challenges and opportunities
|
Piñeirúa, Alicia
|
|
2015
|
15 |
7 |
p. 833-839
7 p.
|
artikel
|
Tijdschrift beschrijving